Antisense oligonucleotide against ABCA4 (Astherna B.V)

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameAntisense oligonucleotide against ABCA4 (Astherna B.V)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRetinal-specific phospholipid-transporting ATPase ABCA4 inhibitors
TargetsRetinal-specific phospholipid-transporting ATPase ABCA4
Therapy Area/IndicationsRetinal Dysplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstherna BV
China Registration ClassN/A

Develop Information

Active CompaniesAstherna BV
Inactive CompaniesN/A
Active IndicationsRetinal Dysplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A